Loading…
Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1,2-dimethylhydrazine in rats
Several studies have revealed that the combination of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), and vitamin D reduces the risk of common types of cancers. Nonetheless, research on the deal concentrations used to test the impact of vitamin D on colon cancer is deficient. Along thes...
Saved in:
Published in: | Biomedical reports 2021-02, Vol.14 (2), p.27, Article 27 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c479t-9fbd9267ed43c9d3cec64eda6a0c580498dbd33ecff60ff7cc752737e4858e403 |
---|---|
cites | |
container_end_page | |
container_issue | 2 |
container_start_page | 27 |
container_title | Biomedical reports |
container_volume | 14 |
creator | Okda, Tarek M Abd-Elghaffar, Sary K Katary, Mohamed A Abd-Alhaseeb, Mohammad M |
description | Several studies have revealed that the combination of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), and vitamin D reduces the risk of common types of cancers. Nonetheless, research on the deal concentrations used to test the impact of vitamin D on colon cancer is deficient. Along these lines, the aim of the present study was to evaluate the possible role of indomethacin and vitamin D as a preventative as well as a therapeutic operator for colon cancer growth induced by dimethylhydrazine (DMH) in male Albino rats. Fifty male albino rats were utilized in this examination; five groups were assigned from the animals (10 animals each): i) control group considered healthy animals; ii) carcinogen group that received DMH only; iii) prophylactic group; iv) vitamin D and indomethacin-treated group; and v) 5-flurouracil (5-FU) group. Western blot technique was used to determine the expression of carcinoembryonic antigen (CEA) and platelet-derived growth factor (PDGF). Overexpression of CEA and PDGF was noted in the carcinogenic group, while expression of CEA and PDGF in the prophylactic, vitamin D and indomethacin and 5-FU groups were markedly reduced. There was a likewise decline in tissue caspase-3 activity and antioxidant parameters in the carcinogenic group, while, there was an increase in these markers in the 5-FU group as well as the prophylactic and vitamin D and indomethacin groups. The combination of vitamin D and indomethacin markedly reduced the incidence and severity of colon cancer. The molecular, biochemical and histopathological analysis related with the oral administration of vitamin D and indomethacin display its capacity to limit the frequency of colorectal cancer. |
doi_str_mv | 10.3892/br.2020.1403 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7780749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A649161863</galeid><sourcerecordid>A649161863</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-9fbd9267ed43c9d3cec64eda6a0c580498dbd33ecff60ff7cc752737e4858e403</originalsourceid><addsrcrecordid>eNptUk1r3DAQNaWhCUluPRdBr_FWlmRLuhTCtk0LgV7Ss5BHo6yCLW1l78L2X_QfV5tstg1UH2iYefOYJ15VvW3ogivNPvR5wSiji0ZQ_qo6Y1ToWgvBXh9jLk6ry2l6oGVpSVmr3lSnnAuqVNecVb-XKxzTOuMW4xy2SGx05c4BbATMxELJhjngRJInIbo04ryyEOIjspTsWOJPBNLYh2jnkCIpB9KQMsJsB3JgKr0bQEf6HWmuWO3Cnmg3rHYu218hYgGQbOfpojrxdpjw8vCeVz--fL5bfq1vv998W17f1iCknmvte6dZJ9EJDtpxQOgEOttZCq0q2pXrHecI3nfUewkgWya5RKFaheW7zquPT7zrTT-ig6I_28Gscxht3plkg3lZiWFl7tPWSKmoFLoQvD8Q5PRzg9NsHtImxzKzYUK2tG07Jv6i7u2AJkSfChmMYQJz3QnddI3qeEEt_oMq2-EYIEX0oeRfNFw9NUBO05TRHwdvqNlbw_TZ7K1h9tYo8Hf_ij2Cn43A_wASC7cA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2475055624</pqid></control><display><type>article</type><title>Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1,2-dimethylhydrazine in rats</title><source>PubMed Central</source><creator>Okda, Tarek M ; Abd-Elghaffar, Sary K ; Katary, Mohamed A ; Abd-Alhaseeb, Mohammad M</creator><creatorcontrib>Okda, Tarek M ; Abd-Elghaffar, Sary K ; Katary, Mohamed A ; Abd-Alhaseeb, Mohammad M</creatorcontrib><description>Several studies have revealed that the combination of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), and vitamin D reduces the risk of common types of cancers. Nonetheless, research on the deal concentrations used to test the impact of vitamin D on colon cancer is deficient. Along these lines, the aim of the present study was to evaluate the possible role of indomethacin and vitamin D as a preventative as well as a therapeutic operator for colon cancer growth induced by dimethylhydrazine (DMH) in male Albino rats. Fifty male albino rats were utilized in this examination; five groups were assigned from the animals (10 animals each): i) control group considered healthy animals; ii) carcinogen group that received DMH only; iii) prophylactic group; iv) vitamin D and indomethacin-treated group; and v) 5-flurouracil (5-FU) group. Western blot technique was used to determine the expression of carcinoembryonic antigen (CEA) and platelet-derived growth factor (PDGF). Overexpression of CEA and PDGF was noted in the carcinogenic group, while expression of CEA and PDGF in the prophylactic, vitamin D and indomethacin and 5-FU groups were markedly reduced. There was a likewise decline in tissue caspase-3 activity and antioxidant parameters in the carcinogenic group, while, there was an increase in these markers in the 5-FU group as well as the prophylactic and vitamin D and indomethacin groups. The combination of vitamin D and indomethacin markedly reduced the incidence and severity of colon cancer. The molecular, biochemical and histopathological analysis related with the oral administration of vitamin D and indomethacin display its capacity to limit the frequency of colorectal cancer.</description><identifier>ISSN: 2049-9434</identifier><identifier>EISSN: 2049-9442</identifier><identifier>DOI: 10.3892/br.2020.1403</identifier><identifier>PMID: 33408861</identifier><language>eng</language><publisher>England: Spandidos Publications</publisher><subject>1,2-Dimethylhydrazine ; Alfacalcidol ; Anesthesia ; Animals ; Anticancer properties ; Antigens ; Antioxidants ; Arthritis ; Calcifediol ; Calciferol ; Cancer ; Cancer therapies ; Carcinoembryonic antigen ; Carcinogens ; Caspase-3 ; CEA (Oncology) ; Cell adhesion & migration ; Colon ; Colon cancer ; Colorectal cancer ; Colorectal carcinoma ; Dimethylhydrazines ; Ethylenediaminetetraacetic acid ; Growth factors ; Health aspects ; Homogenization ; Indomethacin ; Inflammation ; Inflammatory diseases ; Mortality ; Nonsteroidal anti-inflammatory drugs ; Oncology, Experimental ; Oral administration ; Platelet-derived growth factor ; Prevention ; Proteins ; Tumors ; Vitamin D</subject><ispartof>Biomedical reports, 2021-02, Vol.14 (2), p.27, Article 27</ispartof><rights>Copyright: © Okda et al.</rights><rights>COPYRIGHT 2021 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2021</rights><rights>Copyright: © Okda et al. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-9fbd9267ed43c9d3cec64eda6a0c580498dbd33ecff60ff7cc752737e4858e403</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780749/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780749/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33408861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okda, Tarek M</creatorcontrib><creatorcontrib>Abd-Elghaffar, Sary K</creatorcontrib><creatorcontrib>Katary, Mohamed A</creatorcontrib><creatorcontrib>Abd-Alhaseeb, Mohammad M</creatorcontrib><title>Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1,2-dimethylhydrazine in rats</title><title>Biomedical reports</title><addtitle>Biomed Rep</addtitle><description>Several studies have revealed that the combination of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), and vitamin D reduces the risk of common types of cancers. Nonetheless, research on the deal concentrations used to test the impact of vitamin D on colon cancer is deficient. Along these lines, the aim of the present study was to evaluate the possible role of indomethacin and vitamin D as a preventative as well as a therapeutic operator for colon cancer growth induced by dimethylhydrazine (DMH) in male Albino rats. Fifty male albino rats were utilized in this examination; five groups were assigned from the animals (10 animals each): i) control group considered healthy animals; ii) carcinogen group that received DMH only; iii) prophylactic group; iv) vitamin D and indomethacin-treated group; and v) 5-flurouracil (5-FU) group. Western blot technique was used to determine the expression of carcinoembryonic antigen (CEA) and platelet-derived growth factor (PDGF). Overexpression of CEA and PDGF was noted in the carcinogenic group, while expression of CEA and PDGF in the prophylactic, vitamin D and indomethacin and 5-FU groups were markedly reduced. There was a likewise decline in tissue caspase-3 activity and antioxidant parameters in the carcinogenic group, while, there was an increase in these markers in the 5-FU group as well as the prophylactic and vitamin D and indomethacin groups. The combination of vitamin D and indomethacin markedly reduced the incidence and severity of colon cancer. The molecular, biochemical and histopathological analysis related with the oral administration of vitamin D and indomethacin display its capacity to limit the frequency of colorectal cancer.</description><subject>1,2-Dimethylhydrazine</subject><subject>Alfacalcidol</subject><subject>Anesthesia</subject><subject>Animals</subject><subject>Anticancer properties</subject><subject>Antigens</subject><subject>Antioxidants</subject><subject>Arthritis</subject><subject>Calcifediol</subject><subject>Calciferol</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Carcinoembryonic antigen</subject><subject>Carcinogens</subject><subject>Caspase-3</subject><subject>CEA (Oncology)</subject><subject>Cell adhesion & migration</subject><subject>Colon</subject><subject>Colon cancer</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Dimethylhydrazines</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Growth factors</subject><subject>Health aspects</subject><subject>Homogenization</subject><subject>Indomethacin</subject><subject>Inflammation</subject><subject>Inflammatory diseases</subject><subject>Mortality</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Oncology, Experimental</subject><subject>Oral administration</subject><subject>Platelet-derived growth factor</subject><subject>Prevention</subject><subject>Proteins</subject><subject>Tumors</subject><subject>Vitamin D</subject><issn>2049-9434</issn><issn>2049-9442</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNptUk1r3DAQNaWhCUluPRdBr_FWlmRLuhTCtk0LgV7Ss5BHo6yCLW1l78L2X_QfV5tstg1UH2iYefOYJ15VvW3ogivNPvR5wSiji0ZQ_qo6Y1ToWgvBXh9jLk6ry2l6oGVpSVmr3lSnnAuqVNecVb-XKxzTOuMW4xy2SGx05c4BbATMxELJhjngRJInIbo04ryyEOIjspTsWOJPBNLYh2jnkCIpB9KQMsJsB3JgKr0bQEf6HWmuWO3Cnmg3rHYu218hYgGQbOfpojrxdpjw8vCeVz--fL5bfq1vv998W17f1iCknmvte6dZJ9EJDtpxQOgEOttZCq0q2pXrHecI3nfUewkgWya5RKFaheW7zquPT7zrTT-ig6I_28Gscxht3plkg3lZiWFl7tPWSKmoFLoQvD8Q5PRzg9NsHtImxzKzYUK2tG07Jv6i7u2AJkSfChmMYQJz3QnddI3qeEEt_oMq2-EYIEX0oeRfNFw9NUBO05TRHwdvqNlbw_TZ7K1h9tYo8Hf_ij2Cn43A_wASC7cA</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Okda, Tarek M</creator><creator>Abd-Elghaffar, Sary K</creator><creator>Katary, Mohamed A</creator><creator>Abd-Alhaseeb, Mohammad M</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20210201</creationdate><title>Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1,2-dimethylhydrazine in rats</title><author>Okda, Tarek M ; Abd-Elghaffar, Sary K ; Katary, Mohamed A ; Abd-Alhaseeb, Mohammad M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-9fbd9267ed43c9d3cec64eda6a0c580498dbd33ecff60ff7cc752737e4858e403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>1,2-Dimethylhydrazine</topic><topic>Alfacalcidol</topic><topic>Anesthesia</topic><topic>Animals</topic><topic>Anticancer properties</topic><topic>Antigens</topic><topic>Antioxidants</topic><topic>Arthritis</topic><topic>Calcifediol</topic><topic>Calciferol</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Carcinoembryonic antigen</topic><topic>Carcinogens</topic><topic>Caspase-3</topic><topic>CEA (Oncology)</topic><topic>Cell adhesion & migration</topic><topic>Colon</topic><topic>Colon cancer</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Dimethylhydrazines</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Growth factors</topic><topic>Health aspects</topic><topic>Homogenization</topic><topic>Indomethacin</topic><topic>Inflammation</topic><topic>Inflammatory diseases</topic><topic>Mortality</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Oncology, Experimental</topic><topic>Oral administration</topic><topic>Platelet-derived growth factor</topic><topic>Prevention</topic><topic>Proteins</topic><topic>Tumors</topic><topic>Vitamin D</topic><toplevel>online_resources</toplevel><creatorcontrib>Okda, Tarek M</creatorcontrib><creatorcontrib>Abd-Elghaffar, Sary K</creatorcontrib><creatorcontrib>Katary, Mohamed A</creatorcontrib><creatorcontrib>Abd-Alhaseeb, Mohammad M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Biological Science Journals</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biomedical reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okda, Tarek M</au><au>Abd-Elghaffar, Sary K</au><au>Katary, Mohamed A</au><au>Abd-Alhaseeb, Mohammad M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1,2-dimethylhydrazine in rats</atitle><jtitle>Biomedical reports</jtitle><addtitle>Biomed Rep</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>14</volume><issue>2</issue><spage>27</spage><pages>27-</pages><artnum>27</artnum><issn>2049-9434</issn><eissn>2049-9442</eissn><abstract>Several studies have revealed that the combination of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), and vitamin D reduces the risk of common types of cancers. Nonetheless, research on the deal concentrations used to test the impact of vitamin D on colon cancer is deficient. Along these lines, the aim of the present study was to evaluate the possible role of indomethacin and vitamin D as a preventative as well as a therapeutic operator for colon cancer growth induced by dimethylhydrazine (DMH) in male Albino rats. Fifty male albino rats were utilized in this examination; five groups were assigned from the animals (10 animals each): i) control group considered healthy animals; ii) carcinogen group that received DMH only; iii) prophylactic group; iv) vitamin D and indomethacin-treated group; and v) 5-flurouracil (5-FU) group. Western blot technique was used to determine the expression of carcinoembryonic antigen (CEA) and platelet-derived growth factor (PDGF). Overexpression of CEA and PDGF was noted in the carcinogenic group, while expression of CEA and PDGF in the prophylactic, vitamin D and indomethacin and 5-FU groups were markedly reduced. There was a likewise decline in tissue caspase-3 activity and antioxidant parameters in the carcinogenic group, while, there was an increase in these markers in the 5-FU group as well as the prophylactic and vitamin D and indomethacin groups. The combination of vitamin D and indomethacin markedly reduced the incidence and severity of colon cancer. The molecular, biochemical and histopathological analysis related with the oral administration of vitamin D and indomethacin display its capacity to limit the frequency of colorectal cancer.</abstract><cop>England</cop><pub>Spandidos Publications</pub><pmid>33408861</pmid><doi>10.3892/br.2020.1403</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2049-9434 |
ispartof | Biomedical reports, 2021-02, Vol.14 (2), p.27, Article 27 |
issn | 2049-9434 2049-9442 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7780749 |
source | PubMed Central |
subjects | 1,2-Dimethylhydrazine Alfacalcidol Anesthesia Animals Anticancer properties Antigens Antioxidants Arthritis Calcifediol Calciferol Cancer Cancer therapies Carcinoembryonic antigen Carcinogens Caspase-3 CEA (Oncology) Cell adhesion & migration Colon Colon cancer Colorectal cancer Colorectal carcinoma Dimethylhydrazines Ethylenediaminetetraacetic acid Growth factors Health aspects Homogenization Indomethacin Inflammation Inflammatory diseases Mortality Nonsteroidal anti-inflammatory drugs Oncology, Experimental Oral administration Platelet-derived growth factor Prevention Proteins Tumors Vitamin D |
title | Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1,2-dimethylhydrazine in rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A00%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemopreventive%20and%20anticancer%20activities%20of%20indomethacin%20and%20vitamin%20D%20combination%20on%20colorectal%20cancer%20induced%20by%201,2-dimethylhydrazine%20in%20rats&rft.jtitle=Biomedical%20reports&rft.au=Okda,%20Tarek%20M&rft.date=2021-02-01&rft.volume=14&rft.issue=2&rft.spage=27&rft.pages=27-&rft.artnum=27&rft.issn=2049-9434&rft.eissn=2049-9442&rft_id=info:doi/10.3892/br.2020.1403&rft_dat=%3Cgale_pubme%3EA649161863%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c479t-9fbd9267ed43c9d3cec64eda6a0c580498dbd33ecff60ff7cc752737e4858e403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2475055624&rft_id=info:pmid/33408861&rft_galeid=A649161863&rfr_iscdi=true |